Revascular Therapeutics, maker of a device that helps doctors clear blockages in major arteries, has tacked on $3 million to a second round of funding, bringing its total to $11 million, reports VentureWire. The Sunnyvale, Calif., company hopes to add $1 million more to fully fund a study on its lead product.
Revascular's device -- which combines light and sound to guide physicians through vein-clearing procedures -- is under testing in Europe expected to finish in June or July. After that, the company will submit it to the Food and Drug Administration for approval. It is currently looking for a distribution or acquisition deal to take the product commercial.
The newest funding came from Adams Street Partners, Bio-Star Equity Fund, Charter Life Sciences and Latterell Venture Partners. The company, which doesn't have a web site, has now raised $14.5 million to date.